Inactive Instrument

Shandong Longlive Bio-Technology Co., Ltd. Stock

Equities

002604

CNE1000015T8

Food Processing

Dynamic Chart
Shandong Longlive Bio-Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Shandong Longlive Bio-Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019 CI
Shandong Longlive Bio-Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019 CI
Shandong Longlive Bio-Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Shandong Longlive Bio-Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Shandong Longlive Bio-Technology Co., Ltd. completed the acquisition of Xiamen Kuaiyun Information Technology Co., Ltd. from Huang Xiaorong and Yang Feng. CI
Shandong Longlive Bio-Technology Co., Ltd. completed the acquisition of 50% stake in Zhaorong Lianhe Technology Development Co., Ltd. from Zhang Dong and Sheng Yong. CI
Shandong Longlive Bio-Technology Co., Ltd. agreed to acquire 50% stake in Zhaorong Lianhe Technology Development Co., Ltd. from Zhang Dong and Sheng Yong for approximately CNY 440 million. CI
Shandong Longlive Bio-Technology Co., Ltd. agreed to acquire Xiamen Kuaiyun Information Technology Co., Ltd. from Huang Xiaorong and Yang Feng for CNY 580 million. CI
Shandong Longlive Bio-Technology Declares 2014 Final Cash Dividend on Class A Shares Payable on 05 June 2015 CI
Shandong Longlive Bio-Technology Co., Ltd. Announces Profit Distribution Proposal for 2014 CI
Shandong Longlive Bio-Technology, Guangzhou Institute of Energy Conversion and Chinese Academy of Sciences Sign Strategic Partnership Agreement CI
Certain shares of Shandong Longlive Bio-Technology Co., Ltd.'s A Shares are subject to a Lock-Up Agreement Ending on 28-JUL-2014. CI
Shandong Longlive Bio-Technology Co., Ltd. Proposes Profit Distribution for 2013 CI
Shandong Longlive Bio-Technology Co., Ltd. Announces 2012 Final Distribution Plan, Payable on 24 May 2013 CI
More news
Shandong Longlive Bio-technology Co., Ltd. is a China-based company principally engaged in the production and trading of functional sugars, as well as Internet business. The Company's functional sugar products include xylo-oligosaccharide, xylose, xylitol, arabinose and cellulosic ethanol, among others. The Company is also involved in digital marketing and digital distribution businesses. The Company provides Internet products and services, including mobile phone games, text content reading, comic and animation and Interactive Voice Response (IVR).
More about the company
  1. Stock Market
  2. Equities
  3. 002604 Stock